Chronic heart failure and skeletal muscle catabolism: effects of exercise training.

Universität Leipzig, Herzzentrum GmbH, Klinik für Innere Medizin/Kardiologie, Russenstr. 19, 04289 Leipzig, Germany.
International Journal of Cardiology (Impact Factor: 6.18). 10/2002; 85(1):141-9. DOI: 10.1016/S0167-5273(02)00243-7
Source: PubMed

ABSTRACT Although the clinical picture of cardiac cachexia is well-known in patients with advanced chronic heart failure (CHF) the factors that determine who is at risk for this progressive catabolic syndrome and who is not remain unclear. Different endocrine systems have been accused of being involved in this process: an imbalance between catabolic and anabolic steroids with an elevated cortisol/dihydroepiandrosterone ratio, an increased resting metabolic rate due to high levels of circulating catecholamines, various cytokines are activated in CHF (i.e. TNF-alpha, IL-6, IL-1beta and others), and elevated levels of growth hormone (GH) with inappropriately normal or low serum levels of insulin-like growth factor-I (IGF-I) have been described in cardiac cachexia. These catabolic factors contribute to peripheral muscle atrophy, augment the expression of the inducible nitric oxide synthase (iNOS), which in turn inhibits the aerobic cellular metabolism. The present review examines whether the catabolic factors can be influenced by a classical anabolic intervention: regular physical exercise training. Long-term training programs increase skeletal muscle cytochrome c oxidase activity and are associated with reduced local expression of pro-inflammatory cytokines as well as iNOS, and augment local IGF-I production. In concert, these beneficial effects of exercise training may help to retard the catabolic process in CHF finally leading to cardiac cachexia and death.


Available from: Stephan Gielen, May 29, 2015
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Declining physical function is common among systolic heart failure (HF) patients and heralds poor clinical outcomes. We hypothesized that coordinated shifts in expression of ubiquitin mediated atrophy-promoting genes are associated with muscle atrophy and contribute to decreased physical function. Systolic HF patients (left ventricular ejection fraction [LVEF] ≤40%) underwent skeletal muscle biopsies (non-dominant vastus lateralis) and comprehensive physical assessments. Skeletal muscle gene expression was assessed using real-time polymerase chain reaction. Aerobic function was assessed using cardiopulmonary exercise and 6 minute walk tests. Strength capacity was assessed using pneumatic leg press (maximum strength and power). Serological inflammatory markers were also assessed. 54 male patients (66.6±10.0 years) were studied; 24 systolic HF patients (mean LVEF=28.9±7.8%) and 30 age-matched controls. Aerobic and strength parameters were diminished in HF vs. controls. FoxO1 and FoxO3 were increased in HF vs. controls (7.9+6.2 vs. 5.0±3.5, 6.5 ±4.3 vs. 4.3±2.8, respectively, p≤0.05 in both). However, atrogin-1 and MuRF-1 were similar in both groups. PGC-1α was also increased in HF (7.9±5.4 vs. 5.3±3.6, p<0.05). Muscle levels of IGF-1 as well as serum levels of TNF-α, CRP, IL-1β, and IL-6 were similar in HF and controls. Expression of the atrophy-promoting genes FoxO1 and FoxO3 were increased in skeletal muscle in systolic HF compared to controls, but other atrophy gene expression patterns (atrogin-1 and MuRF-1) as well as growth promoting patterns (IGF-1) were similar. PGC-1α, a gene critical in enhancing mitochondrial function and moderating FoxO activity, may play an important counter-regulatory role to offset ubiquitin pathway-mediated functional decrements.
    Journal of cardiac failure 04/2014; DOI:10.1016/j.cardfail.2014.03.007 · 3.07 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Higher body mass index (BMI) is associated with incident heart failure (HF), but paradoxically associated with better prognosis, recognized as the obesity paradox in HF. However, the impact of BMI on detailed prognosis on HF and the mechanism of obesity paradox remain still unclearMethods We researched consecutive 648 patients admitted for HF: Underweight (BMI < 18.5 kg/m2, n=86), Normal (18.5 ≤ BMI < 25, n=380), Overweight (25 ≤ BMI <30, n=147), and Obese (30 ≤ BMI, n=35), and compared the results from their laboratory tests and echocardiography. We also followed cardiac and all-cause mortalityResultsObese group had a higher prevalence of obesity-related co-morbidity (hypertension, diabetes, dyslipidemia), however, tumor necrosis factor-α, adiponectin, troponin T, and systolic pulmonary arterial pressure were higher in the Underweight group than in the other groups (P<0.05, respectively). Left and right ventricular systolic function did not differ among the groups. In the Kaplan-Meier analysis, cardiac and all-cause mortality progressively increased from Obese to Overweight, Normal and Underweight group. Importantly, in the Cox proportional hazard analyses after adjusting for known risk factors, BMI was an independent predictor of cardiac and all-cause mortality (P<0.01, respectively) in HF patientsConclusionsBMI was an independent predictor of cardiac death and all-cause mortality in HF patients. Furthermore, lower BMI was associated with higher circulating levels of tumor necrosis factor-α, adiponectin and troponin T, and higher systolic pulmonary arterial pressureThis article is protected by copyright. All rights reserved.
    European Journal of Clinical Investigation 10/2014; DOI:10.1111/eci.12354 · 2.83 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aerobic exercise training (AET) induces several skeletal muscle changes, improving aerobic exercise capacity and health. Conversely, to the positive effects of AET, the cachexia syndrome is characterized by skeletal muscle wasting. Cachexia is a multifactorial disorder that occurs and is associated with other chronic diseases such as heart failure and cancer. In these diseases, an overactivation of ubiquitin-proteasome and autophagy systems associated with a reduction in protein synthesis culminates in severe skeletal muscle wasting and, in the last instance, patient's death. In contrast, AET may recycle and enhance many protein expression and enzyme activities, counteracting metabolism impairment and muscle atrophy. Therefore, the aim of the current review was to discuss the supposed therapeutic effects of AET on skeletal muscle wasting in both cardiac and cancer cachexia. Copyright © 2014. Published by Elsevier Inc.
    Life Sciences 12/2014; 125. DOI:10.1016/j.lfs.2014.11.029 · 2.30 Impact Factor